Listed

Lexeo Therapeutics, Inc.

LXEONasdaqCIK 1907108HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$28.0m, Q2 FY2026
Net income−$25.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m17.2Research and development, Q3 FY2023, three months to 2023-09-30$17.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0000950170-24-125943.Report this figure8.2Research and development, Q4 FY2023, three months to 2023-12-31$8.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-24, accession 0000950170-25-043486. Derived: 12-month figure less the 9-month figure.Report this figure15.7Research and development, Q1 FY2024, three months to 2024-03-31$15.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0000950170-25-068536.Report this figure16.6Research and development, Q2 FY2024, three months to 2024-06-30$16.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108427.Report this figure23.4Research and development, Q3 FY2024, three months to 2024-09-30$23.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure18.4Research and development, Q4 FY2024, three months to 2024-12-31$18.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001193125-26-132085. Derived: 12-month figure less the 9-month figure.Report this figure17.2Research and development, Q1 FY2025, three months to 2025-03-31$17.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure14.7Research and development, Q2 FY2025, three months to 2025-06-30$14.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure15.7Research and development, Q3 FY2025, three months to 2025-09-30$15.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure16.2Research and development, Q4 FY2025, three months to 2025-12-31$16.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001193125-26-132085. Derived: 12-month figure less the 9-month figure.Report this figure15.7Research and development, Q1 FY2026, three months to 2026-03-31$15.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure19.0Research and development, Q2 FY2026, three months to 2026-06-30$19.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure
Operating income$m(20.3)Operating income, Q3 FY2023, three months to 2023-09-30−$20.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-125943.Report this figure(15.0)Operating income, Q4 FY2023, three months to 2023-12-31−$15.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-24, accession 0000950170-25-043486. Derived: 12-month figure less the 9-month figure.Report this figure(23.3)Operating income, Q1 FY2024, three months to 2024-03-31−$23.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-068536.Report this figure(23.6)Operating income, Q2 FY2024, three months to 2024-06-30−$23.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108427.Report this figure(31.5)Operating income, Q3 FY2024, three months to 2024-09-30−$31.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure(27.4)Operating income, Q4 FY2024, three months to 2024-12-31−$27.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-132085. Derived: 12-month figure less the 9-month figure.Report this figure(33.8)Operating income, Q1 FY2025, three months to 2025-03-31−$33.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure(30.7)Operating income, Q2 FY2025, three months to 2025-06-30−$30.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure(21.6)Operating income, Q3 FY2025, three months to 2025-09-30−$21.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure(23.1)Operating income, Q4 FY2025, three months to 2025-12-31−$23.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-132085. Derived: 12-month figure less the 9-month figure.Report this figure(22.3)Operating income, Q1 FY2026, three months to 2026-03-31−$22.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure(28.0)Operating income, Q2 FY2026, three months to 2026-06-30−$28.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure
Interest expense$m0.1Interest expense, Q3 FY2023, three months to 2023-09-30$52.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-12-11, accession 0000950170-23-069192.Report this figure0.1Interest expense, Q4 FY2023, three months to 2023-12-31$50.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-11, accession 0000950170-24-028941. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$37.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0000950170-24-056247.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$35.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-12, accession 0000950170-24-095057.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$35.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$30.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-30, accession 0001193125-26-132085. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$28.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$25.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$22.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$20.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-30, accession 0001193125-26-132085. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$17.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$14.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure
Net income$m(20.1)Net income, Q3 FY2023, three months to 2023-09-30−$20.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-125943.Report this figure(14.2)Net income, Q4 FY2023, three months to 2023-12-31−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-24, accession 0000950170-25-043486. Derived: 12-month figure less the 9-month figure.Report this figure(21.7)Net income, Q1 FY2024, three months to 2024-03-31−$21.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure(21.2)Net income, Q2 FY2024, three months to 2024-06-30−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure(29.5)Net income, Q3 FY2024, three months to 2024-09-30−$29.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure(25.9)Net income, Q4 FY2024, three months to 2024-12-31−$25.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-132085. Derived: 12-month figure less the 9-month figure.Report this figure(32.7)Net income, Q1 FY2025, three months to 2025-03-31−$32.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure(26.1)Net income, Q2 FY2025, three months to 2025-06-30−$26.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure(20.3)Net income, Q3 FY2025, three months to 2025-09-30−$20.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure(21.0)Net income, Q4 FY2025, three months to 2025-12-31−$21.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345724. Derived: 12-month figure less the 9-month figure.Report this figure(20.2)Net income, Q1 FY2026, three months to 2026-03-31−$20.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure(25.9)Net income, Q2 FY2026, three months to 2026-06-30−$25.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure
Diluted EPS$ per share(12.36)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$12.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0000950170-24-125943.Report this figurenot reported(0.77)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0000950170-25-068536.Report this figure(0.64)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108427.Report this figure(0.89)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.89 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figurenot reported(0.99)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure(0.60)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure(0.33)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figurenot reported(0.25)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure(0.30)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure
Basic EPS$ per share(12.36)Basic EPS, Q3 FY2023, three months to 2023-09-30−$12.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0000950170-24-125943.Report this figurenot reported(0.77)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.77 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0000950170-25-068536.Report this figure(0.64)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-108427.Report this figure(0.89)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.89 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figurenot reported(0.99)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure(0.60)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure(0.33)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figurenot reported(0.25)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure(0.30)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure

Balance sheet

Cash and equivalents$92.8m, Q2 FY2026
Shareholders' equity$235.1m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m35.4Cash and equivalents, Q3 FY2023, at 2023-09-30$35.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-12-11, accession 0000950170-23-069192.Report this figure121Cash and equivalents, FY2023, at 2023-12-31$121.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-24, accession 0000950170-25-043486.Report this figure195Cash and equivalents, Q1 FY2024, at 2024-03-31$195.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0000950170-24-056247.Report this figure175Cash and equivalents, Q2 FY2024, at 2024-06-30$175.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-12, accession 0000950170-24-095057.Report this figure157Cash and equivalents, Q3 FY2024, at 2024-09-30$157.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0000950170-24-125943.Report this figure35.0Cash and equivalents, FY2024, at 2024-12-31$35.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001193125-26-132085.Report this figure28.9Cash and equivalents, Q1 FY2025, at 2025-03-31$28.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0000950170-25-068536.Report this figure35.5Cash and equivalents, Q2 FY2025, at 2025-06-30$35.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0000950170-25-108427.Report this figure41.0Cash and equivalents, Q3 FY2025, at 2025-09-30$41.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure63.0Cash and equivalents, FY2025, at 2025-12-31$63.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure71.8Cash and equivalents, Q1 FY2026, at 2026-03-31$71.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure92.8Cash and equivalents, Q2 FY2026, at 2026-06-30$92.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure
Current assets$m38.9Current assets, Q3 FY2023, at 2023-09-30$38.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-12-11, accession 0000950170-23-069192.Report this figure124Current assets, FY2023, at 2023-12-31$124.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-24, accession 0000950170-25-043486.Report this figure198Current assets, Q1 FY2024, at 2024-03-31$198.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056247.Report this figure177Current assets, Q2 FY2024, at 2024-06-30$177.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095057.Report this figure159Current assets, Q3 FY2024, at 2024-09-30$159.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-125943.Report this figure126Current assets, FY2024, at 2024-12-31$126.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001193125-26-132085.Report this figure105Current assets, Q1 FY2025, at 2025-03-31$105.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-068536.Report this figure140Current assets, Q2 FY2025, at 2025-06-30$140.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108427.Report this figure128Current assets, Q3 FY2025, at 2025-09-30$127.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure188Current assets, FY2025, at 2025-12-31$188.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure201Current assets, Q1 FY2026, at 2026-03-31$200.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure218Current assets, Q2 FY2026, at 2026-06-30$217.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure
Total assets$m54.7Total assets, Q3 FY2023, at 2023-09-30$54.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-12-11, accession 0000950170-23-069192.Report this figure140Total assets, FY2023, at 2023-12-31$139.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-24, accession 0000950170-25-043486.Report this figure213Total assets, Q1 FY2024, at 2024-03-31$213.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056247.Report this figure192Total assets, Q2 FY2024, at 2024-06-30$192.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0000950170-24-095057.Report this figure174Total assets, Q3 FY2024, at 2024-09-30$173.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0000950170-24-125943.Report this figure147Total assets, FY2024, at 2024-12-31$146.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001193125-26-132085.Report this figure126Total assets, Q1 FY2025, at 2025-03-31$125.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0000950170-25-068536.Report this figure176Total assets, Q2 FY2025, at 2025-06-30$176.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-108427.Report this figure144Total assets, Q3 FY2025, at 2025-09-30$143.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure269Total assets, FY2025, at 2025-12-31$268.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure250Total assets, Q1 FY2026, at 2026-03-31$250.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure255Total assets, Q2 FY2026, at 2026-06-30$254.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure
Current liabilities$m23.0Current liabilities, Q3 FY2023, at 2023-09-30$23.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-12-11, accession 0000950170-23-069192.Report this figure17.2Current liabilities, FY2023, at 2023-12-31$17.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-24, accession 0000950170-25-043486.Report this figure21.6Current liabilities, Q1 FY2024, at 2024-03-31$21.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056247.Report this figure18.9Current liabilities, Q2 FY2024, at 2024-06-30$18.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095057.Report this figure26.8Current liabilities, Q3 FY2024, at 2024-09-30$26.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-125943.Report this figure22.8Current liabilities, FY2024, at 2024-12-31$22.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001193125-26-132085.Report this figure30.8Current liabilities, Q1 FY2025, at 2025-03-31$30.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-068536.Report this figure31.6Current liabilities, Q2 FY2025, at 2025-06-30$31.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108427.Report this figure17.3Current liabilities, Q3 FY2025, at 2025-09-30$17.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure16.8Current liabilities, FY2025, at 2025-12-31$16.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure14.2Current liabilities, Q1 FY2026, at 2026-03-31$14.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure15.7Current liabilities, Q2 FY2026, at 2026-06-30$15.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure
Total liabilities$m32.5Total liabilities, Q3 FY2023, at 2023-09-30$32.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-12-11, accession 0000950170-23-069192.Report this figure26.3Total liabilities, FY2023, at 2023-12-31$26.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-24, accession 0000950170-25-043486.Report this figure30.3Total liabilities, Q1 FY2024, at 2024-03-31$30.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056247.Report this figure27.1Total liabilities, Q2 FY2024, at 2024-06-30$27.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0000950170-24-095057.Report this figure34.5Total liabilities, Q3 FY2024, at 2024-09-30$34.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0000950170-24-125943.Report this figure30.1Total liabilities, FY2024, at 2024-12-31$30.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001193125-26-132085.Report this figure37.6Total liabilities, Q1 FY2025, at 2025-03-31$37.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0000950170-25-068536.Report this figure37.9Total liabilities, Q2 FY2025, at 2025-06-30$37.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0000950170-25-108427.Report this figure23.0Total liabilities, Q3 FY2025, at 2025-09-30$23.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure22.0Total liabilities, FY2025, at 2025-12-31$22.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure18.9Total liabilities, Q1 FY2026, at 2026-03-31$18.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure19.8Total liabilities, Q2 FY2026, at 2026-06-30$19.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure
Shareholders' equity$m(163)Shareholders' equity, Q3 FY2023, at 2023-09-30−$162.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0000950170-24-125943.Report this figure114Shareholders' equity, FY2023, at 2023-12-31$113.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001193125-26-132085.Report this figure183Shareholders' equity, Q1 FY2024, at 2024-03-31$182.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure165Shareholders' equity, Q2 FY2024, at 2024-06-30$164.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure139Shareholders' equity, Q3 FY2024, at 2024-09-30$139.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure117Shareholders' equity, FY2024, at 2024-12-31$116.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure88.1Shareholders' equity, Q1 FY2025, at 2025-03-31$88.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure138Shareholders' equity, Q2 FY2025, at 2025-06-30$138.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure121Shareholders' equity, Q3 FY2025, at 2025-09-30$120.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure247Shareholders' equity, FY2025, at 2025-12-31$246.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure231Shareholders' equity, Q1 FY2026, at 2026-03-31$231.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure235Shareholders' equity, Q2 FY2026, at 2026-06-30$235.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure

Cash flow

Operating cash flow−$17.6m, Q2 FY2026
Capital expenditure$7.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(13.9)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$13.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0000950170-24-125943. Derived: 9-month figure less the 6-month figure.Report this figure(14.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$14.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-24, accession 0000950170-25-043486. Derived: 12-month figure less the 9-month figure.Report this figure(14.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$14.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0000950170-25-068536.Report this figure(20.2)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$20.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-108427. Derived: 6-month figure less the 3-month figure.Report this figure(17.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$17.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-265757. Derived: 9-month figure less the 6-month figure.Report this figure(28.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$28.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001193125-26-132085. Derived: 12-month figure less the 9-month figure.Report this figure(21.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$21.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure(27.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$27.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-345724. Derived: 6-month figure less the 3-month figure.Report this figure(29.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$29.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-265757. Derived: 9-month figure less the 6-month figure.Report this figure(20.1)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$20.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001193125-26-132085. Derived: 12-month figure less the 9-month figure.Report this figure(21.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$21.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure(17.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-345724. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0000950170-24-125943. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$73.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-24, accession 0000950170-25-043486. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$185.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0000950170-25-068536.Report this figure0.2Capital expenditure, Q2 FY2024, three months to 2024-06-30$213.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0000950170-25-108427. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$83.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-265757. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001193125-26-132085. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.3Capital expenditure, Q3 FY2025, three months to 2025-09-30$289.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-265757. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001193125-26-132085. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$35.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-345724. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)85.63m, Q2 FY2026
Line itemUnitperiod not labelled2022-09-30period not labelled2023-03-31period not labelled2023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares1.6Diluted shares (weighted), period not labelled, three months to 2022-09-301,643,122 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-12-11, accession 0000950170-23-069192.Report this figure1.6Diluted shares (weighted), period not labelled, three months to 2023-03-311,610,793 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-056247.Report this figure1.6Diluted shares (weighted), period not labelled, three months to 2023-06-301,619,547 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0000950170-24-095057.Report this figure1.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-301,626,734 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0000950170-24-125943.Report this figure28.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3127,979,838 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0000950170-25-068536.Report this figure33.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3033,001,946 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-108427.Report this figure33.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3033,063,153 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure33.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3133,113,991 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure43.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3043,573,628 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure61.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3060,980,867 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-265757.Report this figure81.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3181,183,812 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001193125-26-215678.Report this figure85.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3085,626,751 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure

Shares outstanding: 82.05mShares outstanding, period not labelled, at 2026-08-1082,046,255 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345724.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.